Overexpression of Histone Deacetylase 2 Predicts Unfavorable Prognosis in Human Gallbladder Carcinoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of Histone Deacetylase 2 Predicts Unfavorable Prognosis in Human Gallbladder Carcinoma
Authors
Keywords
Primary gallbladder carcinoma, Histone deacetylase 2, Clinicopathology, Overall survival, Disease-free survival
Journal
PATHOLOGY & ONCOLOGY RESEARCH
Volume 19, Issue 3, Pages 397-403
Publisher
Springer Nature
Online
2012-12-16
DOI
10.1007/s12253-012-9592-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA)
- (2013) Ouaïssi Mehdi et al. PANCREATOLOGY
- HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins
- (2012) Kwang Hwa Jung et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5.erbB2 mice
- (2012) Takuya Kitamura et al. JOURNAL OF HEPATOLOGY
- Physical Association of HDAC1 and HDAC2 with p63 Mediates Transcriptional Repression and Tumor Maintenance in Squamous Cell Carcinoma
- (2011) M. R. Ramsey et al. CANCER RESEARCH
- Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis
- (2011) Jennifer Jurkin et al. CELL CYCLE
- Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer
- (2011) Ali Aghdassi et al. GUT
- A Single Institution Experience with Living Donor Liver Transplantation for Acute-on-Chronic Hepatitis B Liver Failure
- (2011) Zheyu Chen et al. HEPATO-GASTROENTEROLOGY
- Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC
- (2011) Karl Quint et al. VIRCHOWS ARCHIV
- Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression
- (2010) T. Yamaguchi et al. GENES & DEVELOPMENT
- HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells
- (2010) Susanne Schuler et al. Molecular Cancer
- Inhibition of histone deacetylase 10 induces thioredoxin-interacting protein and causes accumulation of reactive oxygen species in SNU-620 human gastric cancer cells
- (2010) Ju-Hee Lee et al. MOLECULES AND CELLS
- Troglitazone inhibits histone deacetylase activity in breast cancer cells
- (2009) G.F. Davies et al. CANCER LETTERS
- Histone deacetylase inhibitor (SAHA) and repression of EZH2 synergistically inhibit proliferation of gallbladder carcinoma
- (2009) Junpei Yamaguchi et al. CANCER SCIENCE
- Role of HDAC1 in senescence, aging, and cancer
- (2009) Danielle Willis-Martinez et al. EXPERIMENTAL GERONTOLOGY
- Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation
- (2009) Reinhard Brunmeir et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? Results of a Japanese Society of Biliary Surgery Survey: A multicenter study
- (2009) Tatsuo Araida et al. SURGERY TODAY
- Lysophosphatidic Acid Protects Cancer Cells from Histone Deacetylase (HDAC) Inhibitor-induced Apoptosis through Activation of HDAC
- (2008) Ganchimeg Ishdorj et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients
- (2008) Hao-Hueng Chang et al. ORAL ONCOLOGY
- Effect of histone deacetylase inhibitor on proliferation of biliary tract cancer cell lines
- (2008) Li-Ning Xu et al. WORLD JOURNAL OF GASTROENTEROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started